LENVIMA 10 mg hard capsules clinical trials
3 indexed studies · 0 currently recruiting
- Ongoing, recruitingPhase I and Phase II (Integrated)- Other
An open-label, multicenter, phase 1b/2 study of E7386 in combination with pembrolizumab in previously treated subjects with selected solid tumors
This study is testing new combinations of medicines (E7386 with pembrolizumab, and sometimes with lenvatinib) for advanced bowel cancer, melanoma, and liver cancer. Researchers want to see if these combinations are safe and if they can shrink tumors.
For: colorectal cancer · melanoma · hepatocellular carcinomaSpain - Ongoing, recruitingHuman Pharmacology (Phase I)- Bioequivalence Study
Comparative Bioavailability of Lenvatinib 10 mg Capsules: A Two-Part, Single-Dose, Open-Label, Randomized, Six-Sequence, Three-Treatment, Three-Period, Crossover Pilot Study in Healthy Subjects Under Fasting and Fed Conditions.
This study looks at how a cancer drug called Lenvatinib is absorbed by the body. It helps us understand if different versions of the drug work the same way, and if food affects this absorption. It's for adults, and you don't need to have cancer to take part.
For: Progressive · locally advanced or metastatic · differentiated (papillary/follicular/Hurthle cell) thyroid carcinomaPortugal - Ongoing, recruitingTherapeutic exploratory (Phase II)
LENVAGIST - A multicentre, comparative, placebo-controlled, double-blinded, phase II study of the efficacy of lenvatinib in patients with locally advanced or metastatic GIST after failure of imatinib and sunitinib
This study is testing a new medicine called lenvatinib (LENVIMA) for people with advanced GIST cancer who haven't responded to previous treatments like imatinib and sunitinib. Researchers want to see if the new drug can stop the cancer from growing for longer.
For: Patients with metastatic GISTFrance